Clinical Trial Update: Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial compares Sapylin (OK-432) inhalation to dexamethasone inhalation for CCRT-induced oral mucositis in nasopharyngeal carcinoma; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Dexamethasone inhalation (dexamethasone)
• Sapylin (OK-432)

Snippet

Sponsor: Affiliated Hospital of Guangdong Medical University | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 3 | Status: RECRUITING